Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

SZSE:002223.SZ

32.43 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 7,890.4267,101.6796,894.3086,725.6874,635.9354,183.3923,541.5632,632.5952,103.7371,681.8021,424.3231,312.2121,170.516883.901537.882401.373289.482231.99212.531
Cost of Revenue 4,016.1213,683.6433,565.2993,182.5442,679.1832,517.3482,136.8741,613.9951,266.0171,009.411887.452822.929754.854572.383332.652283.473202.034163.86153.755
Gross Profit 3,874.3053,418.0363,329.0093,543.1431,956.7511,666.0431,404.6891,018.599837.72672.391536.872489.283415.662311.518205.23117.987.44868.1358.776
Gross Profit Ratio 0.4910.4810.4830.5270.4220.3980.3970.3870.3980.40.3770.3730.3550.3520.3820.2940.3020.2940.277
Reseach & Development Expenses 446.646496.401425.668401.517235.068152.121125.744120.086151.386141.74776.75171.07655.86636.33623.2570000
General & Administrative Expenses 114.507111.938132.689137.44494.73598.42494.31557.10760.76129.7433.64425.03323.85518.30512.94822.70418.34814.2059.965
Selling & Marketing Expenses 1,098.3171,031.466945.006754.062630.089536.804399.769202.791169.31148.438123.97596.2283.52153.67734.117.29510.6537.4197.718
SG&A 1,408.3341,143.4041,077.694891.506724.824635.228494.085259.898230.071178.178157.619121.253107.37671.98247.0484029.00121.62417.683
Other Expenses 3.817217.923216.807211.88164.23669.69237.22532.40533.24750.01246.83818.51841.98910.6324.224-1.3016.99512.25564.921
Operating Expenses 1,851.1631,857.7281,720.1691,504.9021,124.128941.968748.553509.398457.543377.421279.229229.738198.794134.38389.77542.33830.90123.09118.23
Operating Income 2,023.1421,841.8041,688.0472,009.669849.886776.196682.978540.643375.406284.865252.602260.55218.497171.053113.90574.9750.47441.45237.743
Operating Income Ratio 0.2560.2590.2450.2990.1830.1860.1930.2050.1780.1690.1770.1990.1870.1940.2120.1870.1740.1790.178
Total Other Income Expenses Net 813.870.61413.7988.97814.458121.81364.06663.31127.62338.72340.50519.44843.5893.4852.655-1.8920.9228.43662.118
Income Before Tax 2,837.0121,842.4181,701.8442,018.647864.345845.888720.202572.512407.801333.693298.148278.993260.457180.621118.1173.66957.46953.474102.664
Income Before Tax Ratio 0.360.2590.2470.30.1860.2020.2030.2170.1940.1980.2090.2130.2230.2040.220.1840.1990.2310.483
Income Tax Expense 472.362269.728217.82262.037102.7795.00392.66170.92741.11935.80339.58533.92332.59619.30416.96711.65418.97223.50319.359
Net Income 2,395.8531,595.0371,482.4221,759.062752.567727.154592.029500.255364.344297.005258.053244.101226.412160.882100.54261.83237.87331.54958.774
Net Income Ratio 0.3040.2250.2150.2620.1620.1740.1670.190.1730.1770.1810.1860.1930.1820.1870.1540.1310.1360.277
EPS 2.391.611.491.750.750.730.590.530.410.340.30.280.330.190.120.0780.0660.0750.14
EPS Diluted 2.391.611.491.750.750.730.590.530.410.340.30.280.330.190.120.0780.0660.0750.14
EBITDA 2,277.9542,066.1471,980.0742,222.304985.545954.056816.179651.658476.856386.971335.351313.147286.087208.707134.72485.41570.55361.566108.405
EBITDA Ratio 0.2890.2910.2870.330.2130.2280.230.2480.2270.230.2350.2390.2440.2360.250.2130.2440.2650.51